CDKN1B and hepatocellular carcinoma: For instance, miR-26a replacement in HCC was shown to restore control of Cyclin D/E and induce a clear G1 arrest in vivo, and anti-miR-221 allows p27Kip1 to resume its cell cycle braking function, likewise leading to G1–S blockade [83,84,117,119].